Search results

Find out more about the NICE technology appraisal advisory committee B members and their registered interests

Study NICE and LSE's Executive MSc Healthcare Decision-Making

We offer a dedicated training opportunity to achieve competency in curriculum outcome KA7.5.

Guide for lay members who we've invited to sit on one of NICE's committees, panels, or groups.

Our recommendations on the use of highly specialised technologies are made by an independent advisory committee

Read the biographies of our medical technologies advisory committee members.

Learn about NICE's proportionate approach to technology appraisals, which aims to streamline the evaluation process for new health technologies, ensuring timely access to innovative treatments while maintaining rigorous standards.

We're playing a leading role in the AI and digital regulations service which supports the development and adoption of AI and data-driven technologies in health and care.

Tell us about an interventional procedure you think should be assessed by NICE.

Home What NICE does NICE International {"@context":"http://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1

If you’re unsure where to start or your circumstances are unique, we encourage you to get in touch. We’ll work with you to unpick your challenges and find a solution that meets your needs.

The appeal panel is drawn from a group of people approved by the Secretary of State for Health and Social Care to hear appeals.

A step-by-step timeline of the process we used to develop single technology appraisals (STA).

Summaries of the best available evidence for selected medicines that are considered to be of significance to the NHS.

The guidance development timeline